Guardian Bio

Guardian Bio YC Başvurusu

Summer 2022Active

Guardian Bio, Healthcare şirketi olarak Summer 2022 grubunda Y Combinator'dan geçti. Aşağıda: şirketin ne yaptığı, kimin kurduğu ve gerçek YC formunda yeniden yapılandırılmış YC başvurusu.

YC grubu
Summer 2022
Sektör
HealthcareTherapeutics
Ekip büyüklüğü
2
Durum
Active
Lansmanı Yapıldı
2022

Kurucular

  • Ananya Zutshi
    Ananya ZutshiFounder
  • Ricky Barrett
    Ricky BarrettFounder

Guardian Bio ne yapar

Your immune system is your body’s best weapon and defense against cancer. It is only when it is overcome that cancer develops into full blown disease. Dendritic cells sit at the helm of the immune system, directing and dictating immune responses. Data has shown dendritic cells are often dysfunctional in cancer patients, and that this dysfunction is a bottleneck for other therapies. Guardian Bio’s approach is focused on creating a dendritic cell-based product which drives anti-tumor activity through activating the killers of the immune system AND training them against multiple cancer targets. We take stem cells from cancer patients, turn them into specific therapeutic dendritic cells specially trained against that patient’s tumor, and re-introduce them back into the body. Our therapeutic dendritic cells revitalize the killers of the immune system and give them the kickstart they need to fight - and win - against cancer.

Guardian Bio'in YC başvurusu, yeniden yapılandırılmış

Y Combinator başvurusu

Guardian Bio, Summer 2022 dönemi. Gerçek form soruları, herkese açık verilerden yanıtlandı.

  1. Founders2
  2. Company7
  3. Progress7
  4. Idea4
  5. Equity3
  6. Curious2
  7. Batch Preference1

Company

Company name

Guardian Bio

Describe what your company does in 50 characters or less.

Dendritic cell-based platform for cancer therapy

What is your company going to make? Please describe your product and what it does or will do.

We create a dendritic cell therapy for cancer patients. Our product takes stem cells from a patient, turns them into therapeutic dendritic cells trained to recognize that patient's tumor, and puts them back to activate the immune system to fight cancer.

Where do you live now, and where would the company be based after YC?

We currently live in Boston, MA, and the company will be based there after YC as well.

Explain your decision regarding location.

Boston is a hub for biotech and medical research with access to leading hospitals and academic collaborators, which is critical for our work developing cellular therapies.

Tam başvuruda 21 ek cevap

Founders, Progress, Idea, Equity, Curious, Batch Preference tam sürümde. YC Insights'ta, diğer her YC grubu yanında açmak için ücretsiz bir hesap oluşturun.

Sıkça Sorulan Sorular

Bu, Guardian Bio şirketinin gerçek YC başvurusu mu?

Hayır. Y Combinator gönderilen başvuruları gizli tutar. Bu bir yeniden yapılandırmadır: gerçek YC form soruları, Guardian Bio'in kamuya açık verilerinden (lansman notları, kurucu geçmişleri, ürün açıklaması) yanıtlanmıştır. Guardian Bio gibi bir şirketin YC'ye kendisini nasıl sunacağını gösterir, gönderdikleri metni değil.

Guardian Bio hangi YC grubundaydı?

Guardian Bio, Y Combinator Summer 2022 grubundaydı.

Guardian Bio kim tarafından kuruldu?

Guardian Bio, Ananya Zutshi, Ricky Barrett tarafından kuruldu.

Guardian Bio ne iş yapar?

Dendritic cell-based platform for cancer therapy

Tam yeniden oluşturulmuş başvuruyu nasıl okurum?

Ücretsiz bir Round Funded hesabı oluşturun. Guardian Bio'ın başvurusunun tam 26 soruluk versiyonu ve diğer tüm YC batch'leri YC Insights'ta.

Guardian Bio gibi daha fazla YC girişimi